DBV Technologies (DBVT) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free DBVT Stock Alerts $0.67 -0.01 (-1.47%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOptimistic Buy Rating for DBV Technologies with Viaskin’s Market Potential and Regulatory Prospectsmarkets.businessinsider.com - May 8 at 6:42 PMHC Wainwright Trims DBV Technologies (NASDAQ:DBVT) Target Price to $5.00marketbeat.com - May 8 at 4:00 PMBuy Rating Affirmed for DBV Technologies SA Amidst Strong Clinical Progress and Solid Financial Footingmarkets.businessinsider.com - May 8 at 6:37 AMDBV Technologies Reports Q1 2024 Financial Results Amidst Progress and Challengesfinance.yahoo.com - May 8 at 1:37 AMDBVT Stock Earnings: DBV Technologies Beats EPS, Misses Revenue for Q1 2024investorplace.com - May 8 at 1:06 AMDBV Technologies S.A.: DBV Technologies Reports First Quarter 2024 Financial Results and Business Updatefinanznachrichten.de - May 7 at 8:26 PMDBV Technologies Posts Wider 1Q Loss, Reports Going Concern Doubtsmarketwatch.com - May 7 at 8:26 PMDBV Technologies Reports First Quarter 2024 Financial Results and Business Updateglobenewswire.com - May 7 at 4:30 PMStockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT)americanbankingnews.com - May 6 at 2:46 AMCombined General Meeting of May 16, 2024globenewswire.com - April 25 at 4:30 PMInformation regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024finance.yahoo.com - April 4 at 6:05 PMDBV Technologies S.A. (NASDAQ:DBVT) Short Interest Updatemarketbeat.com - April 1 at 9:47 AMDBVT DBV Technologies S.A.seekingalpha.com - March 20 at 6:44 PMShort Interest in DBV Technologies S.A. (NASDAQ:DBVT) Rises By 9.1%marketbeat.com - March 19 at 5:37 PMDBV Technologies S.A. ADRwsj.com - March 15 at 10:42 PMBuy Rating Affirmed for DBV Technologies on Viaskin Patch Development and Positive Trial Outcomesmarkets.businessinsider.com - March 8 at 3:29 PMDBV Technologies S.A. (NASDAQ:DBVT) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 8 at 3:29 PMDBV Technologies (NASDAQ:DBVT) Announces Earnings Results, Beats Estimates By $0.10 EPSmarketbeat.com - March 8 at 11:23 AMDBV Technologies S.A.: DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Documentfinanznachrichten.de - March 8 at 10:28 AMDBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Documentglobenewswire.com - March 8 at 9:33 AMDBV Technologies SA Reports Decrease in Net Loss and Advances Clinical Programs in Full Year ...finance.yahoo.com - March 7 at 11:59 PMDBVT Stock Earnings: DBV Technologies Beats EPS, Beats Revenue for Q4 2023msn.com - March 7 at 11:59 PMDBV Technologies Reports Full Year 2023 Financial Results and Business Updateglobenewswire.com - March 7 at 4:30 PMDBV Technologies (DBVT) Scheduled to Post Earnings on Thursdaymarketbeat.com - March 5 at 10:11 AMDBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024globenewswire.com - March 4 at 4:30 PMBuy Rating Affirmed for DBV Technologies on Strong Viaskin Peanut Patch Clinical Data and Promising Trialsmarkets.businessinsider.com - February 26 at 10:05 AMDBV Technologies S.A. - Depositary Receipt () (DBVT) Price Target Increased by 15.78% to 2.62msn.com - February 24 at 8:49 PMDBV Technologies (NASDAQ:DBVT) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - February 21 at 8:12 AMDBV Technologies S.A.: DBV Technologies to Participate in Upcoming AAAAI 2024 Congressfinanznachrichten.de - February 20 at 9:19 PMDBV Technologies to Participate in Upcoming AAAAI 2024 Congressfinance.yahoo.com - February 20 at 9:19 PMDBV Technologies to Participate in Upcoming AAAAI 2024 Congressglobenewswire.com - February 20 at 4:30 PMDBV Technologies (NASDAQ:DBVT) Share Price Crosses Below Fifty Day Moving Average of $0.89marketbeat.com - February 20 at 5:59 AMEuropean Equities Traded in the US as American Depositary Receipts Fall in Tuesday Tradingmsn.com - February 13 at 1:11 PMDBV Technologies And 2 Other Stocks Under $2 Insiders Are Buyingmsn.com - February 9 at 7:25 AMDBV Technologies (NASDAQ:DBVT) Stock Crosses Above Fifty Day Moving Average of $0.86marketbeat.com - February 1 at 4:19 AMHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFfinance.yahoo.com - January 22 at 12:06 PMEuropean Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Tradingmsn.com - January 9 at 1:23 PMEuropean Equities Traded in the US as American Depositary Receipts Rise in Thursday Tradingmsn.com - January 4 at 11:34 AMDBV Technologies S.A. (NASDAQ:DBVT) Sees Significant Growth in Short Interestmarketbeat.com - December 28 at 9:23 PMDBV Technologies S.A. (NASDAQ:DBVT) Sees Large Decline in Short Interestmarketbeat.com - December 13 at 10:17 PMInformation regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023finance.yahoo.com - December 4 at 8:07 PMDown -25.23% in 4 Weeks, Here's Why You Should You Buy the Dip in DBV Technologies S.A. (DBVT)msn.com - November 27 at 12:59 PMChief Executive Officer at DBV Technologies Acquires Company Stock Options Worth 806,672 Sharesbenzinga.com - November 22 at 4:05 PMPositive EPITOPE Trial Results Bolster Viaskin’s Potential: DBV Technologies SA Receives Buy Ratingmarkets.businessinsider.com - November 13 at 11:52 PMDBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlersmarkets.businessinsider.com - November 9 at 9:24 PMDBV reports positive Phase 3 data for peanut allergy therapy in toddlersmsn.com - November 9 at 9:24 PMMonthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023finance.yahoo.com - November 6 at 6:49 PMPositive Outlook for DBV Technologies: Anticipated Success of COMFORT Toddlers Study and Continuation of VITESSE Trialmarkets.businessinsider.com - November 2 at 11:55 PMDBV Technologies Receives Buy Rating: Efficacy and Safety of Viaskin Patch Backed by Consistent FDA Communications and Successful Trialsmarkets.businessinsider.com - November 2 at 11:55 PMDBV Technologies S.A.: DBV Technologies to Present New Data at ACAAI 2023finanznachrichten.de - November 2 at 6:55 PM Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk Secret Crypto Plot Exposed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. DBVT Media Mentions By Week DBVT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DBVT News Sentiment▼0.230.36▲Average Medical News Sentiment DBVT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DBVT Articles This Week▼111▲DBVT Articles Average Week Get DBV Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vaxart News Molecular Partners News Cardiol Therapeutics News Vigil Neuroscience News Omega Therapeutics News aTyr Pharma News Scilex News Sangamo Therapeutics News bluebird bio News Cardiff Oncology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DBVT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DBV Technologies S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
